CiprofloxacinAnti-Infective AgentsFluoroquinolonesMicrobial Sensitivity TestsAnti-Bacterial AgentsQuinolonesOfloxacinDrug Resistance, BacterialDNA GyraseQuinolinesLevofloxacinDrug Resistance, MicrobialNorfloxacinDNA Topoisomerase IVAza CompoundsNalidixic AcidPefloxacin4-QuinolonesDrug Resistance, Multiple, BacterialPseudomonas aeruginosaAdministration, OralEnoxacinGram-Negative BacteriaFleroxacinDrug Therapy, CombinationStaphylococcus aureusGram-Positive BacteriaPseudomonas InfectionsGram-Negative Bacterial InfectionsCeftriaxoneTreatment OutcomeDNA Topoisomerases, Type IISalmonella paratyphi ACeftazidimeGonorrheaStreptococcus pneumoniaeNeisseria gonorrhoeaeBacterial InfectionsSalmonella typhiEscherichia coliTyphoid FeverColony Count, MicrobialUrinary Tract InfectionsDrug InteractionsBacteria, AerobicDose-Response Relationship, DrugDouble-Blind MethodTime FactorsBacteria, AnaerobicTrimethoprim-Sulfamethoxazole CombinationGentamicinsRifampinArea Under CurveInjections, IntravenousHalf-LifeDocumentationAzithromycinParatyphoid FeverImipenemMutationAmpicillinStaphylococcal InfectionsBacteremiaAmikacinDrug Administration ScheduleCephalosporinsEye Infections, BacterialBacteriaCefuroximeCefotaximeSerum Bactericidal TestKlebsiella pneumoniaeEscherichia coli InfectionsNitrofurantoinSalmonella InfectionsEnterobacteriaceaeTopoisomerase II InhibitorsThienamycinsPiperacillinAzlocillinDoxycyclineDelayed-Action PreparationsTrimethoprimPenicillin ResistanceProspective StudiesDNA, BacterialErythromycinDrug-Related Side Effects and Adverse ReactionsPenicillinsTetracyclineVancomycinDry Powder InhalersCross InfectionGram-Positive Bacterial InfectionsBiological AvailabilityKeratitisMetronidazoleBacterial ProteinsAnti-Infective Agents, UrinaryTobramycin